©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108063
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108063
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108063
Table 2 Encounter diagnoses and procedures, and disposition by sex, n (%)
| Attribute | Overall (n = 1386) | Male (n = 875) | Female (n = 511) | P value |
| Diagnoses | ||||
| Ascites | 1009 (72.8) | 365 (71.4) | 644 (73.6) | 0.3808 |
| Bacteremia | 89 (6.4) | 62 (7.1) | 27 (5.3) | 0.1867 |
| Clostridium difficile infection | 61 (4.4) | 35 (4) | 26 (5.1) | 0.3407 |
| Esophageal variceal bleed | 121 (8.7) | 96 (11) | 25 (4.9) | 0.0001b |
| Hepatic encephalopathy | 575 (41.5) | 376 (43) | 199 (38.9) | 0.1420 |
| Hepatorenal syndrome | 231 (16.7) | 158 (18.1) | 73 (14.3) | 0.0691 |
| Pneumonia | 234 (16.9) | 138 (15.8) | 96 (18.8) | 0.1483 |
| Portal vein thrombosis | 55 (4) | 40 (4.6) | 15 (2.9) | 0.1323 |
| Spontaneous bacterial peritonitis | 1 (0.1) | 0 | 1 (0.1) | 0.4447 |
| Sepsis | 291 (21) | 167 (19.1) | 124 (24.3) | 0.0223a |
| Substance/alcohol use disorder | 1075 (77.6) | 687 (78.5) | 388 (75.9) | 0.2658 |
| Urinary tract infection | 271 (19.6) | 122 (13.9) | 149 (29.2) | < 0.0001b |
| Medications: | ||||
| Use of any vasopressors | 235 (17) | 137 (15.7) | 98 (19.2) | 0.0919 |
| Norepinephrine | 227 (16.4) | 130 (14.9) | 97 (19) | 0.0453a |
| Epinephrine | 58 (4.2) | 39 (4.5) | 19 (3.7) | 0.5074 |
| Vasopressin | 118 (8.5) | 65 (7.4) | 53 (10.4) | 0.0582 |
| Use of steroids | 503 (36.3) | 328 (37.5) | 175 (34.3) | 0.2263 |
| Use of N-acetylcysteine | 137 (9.9) | 82 (9.4) | 55 (10.8) | 0.4023 |
| Procedures: | ||||
| Renal replacement therapy | 36 (2.6) | 18 (2.1) | 18 (3.5) | 0.0980 |
| Hemodialysis | 10 (0.7) | 8 (0.9) | 2 (0.4) | 0.2671 |
| Mechanical ventilation | 252 (18.2) | 149 (17) | 103 (10.8) | 0.1452 |
| Length of stay (days) | ||||
| Median | 5.6 | 5.5 | 5.7 | 0.4989 |
| Range | 0.1-92.7 | 0.1-92.7 | 0.1-75.7 | |
| Disposition | ||||
| Hospice | 56 (4) | 41 (4.7) | 15 (2.9) | 0.1104 |
| Inpatient death | 150 (10.8) | 93 (10.6) | 57 (11.2) | 0.7610 |
| Inpatient death > 48 hours after admission | 122 (8.8) | 74 (8.5) | 48 (9.4) | 0.5529 |
| Inpatient death or hospice | 206 (14.9) | 134 (15.3) | 72 (14.1) | 0.5365 |
- Citation: Harris E, Rhudy C, Roy L, Cloud A, Leyson CD. Sex differences in severity, outcomes, and healthcare utilization in alcohol-associated hepatitis. World J Hepatol 2025; 17(8): 108063
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108063.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108063